May 10 (Reuters) - Delivra Corp DVA.V
* Delivra - signs exclusive licensing deal with ARA-Avanti Rx Analytics for hemp non-psychoactive cannabinoid, terpene and flavonoid formulations and products
* Delivra - with formulation and extraction beginning immediately, we expect products to be in natural product stores, grocery stores and pharmacies in 2018
* Delivra - co, Avanti will own intellectual property, and co will receive a royalty percentage on related gross sales of suite of natural products Source text for Eikon: ID:nCCN6t3nQG Further company coverage: DVA.V